PAM
BIOA

Panagora Asset Management’s BioAmber Inc. BIOA Stock Holding History

Panagora Asset Management’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-3,817
Closed -$10K – 2629
2017
Q2 		$10K Buy
+3,817
New +$8.77K ﹤0.01% 2466

Other funds holding BIOA

NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
RS
Robeco Schweiz Zurich, Switzerland $6.23B AUM 86.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Panagora Asset Management's BIOA Position: Q3 2017 in Review

Panagora Asset Management sold out of BioAmber Inc. (BIOA) in Q3 2017, closing a stake of 3,817 shares — an estimated $10K sold.

Panagora Asset Management first reported a position in BIOA in Q2 2017 and held it in 1 quarter. The position peaked at $10K in Q2 2017. 30 funds tracked by Wall St. Rank hold BIOA as of Q3 2017.

  • Panagora Asset Management reported no remaining BioAmber Inc. position as of Q3 2017 after selling out during the quarter.
  • Panagora Asset Management sold 3,817 BioAmber Inc. shares in Q3 2017, an estimated $10K.
  • Panagora Asset Management first reported a position in BioAmber Inc. in Q2 2017 and held it in 1 quarter.
  • Panagora Asset Management's BioAmber Inc. position peaked at $10K in Q2 2017.
  • 30 funds tracked by Wall St. Rank held BioAmber Inc. as of Q3 2017.

Based on Panagora Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.